Terms: = Breast cancer AND Beta-hCG AND Treatment
17 results:
1. [Human chorionic gonadotropin-secreting gonadoblastomas in a girl of 45, X Turner syndrome: a case report and literature review].
Zheng RJ; Chen QL; Ma HM; Liu HD; Chen JP; Liang GS; Chen J; Zhang YY; Li S; Guo B; Wang ML; Du M
Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1202-1206. PubMed ID: 36319158
[No Abstract] [Full Text] [Related]
2. The pleura and the endocrine system.
Sorino C; Negri S; Spanevello A; Feller-Kopman D
Eur J Intern Med; 2020 Feb; 72():34-37. PubMed ID: 31918926
[TBL] [Abstract] [Full Text] [Related]
3. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
[TBL] [Abstract] [Full Text] [Related]
4. BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression.
Nadhan R; Vaman JV; Sengodan SK; Hemalatha SK; Chellappan N; Sadasivan S; Pasuthottiyil Varkey A; Yesodharan S; Raji Sathyanpillai K; Bhuvaneswari Venugopal AK; Prameelakumari Sreenivasan S; Rajan A; Latha NR; Varghese GR; Thankappan R; Achyutuni S; Sreekumar Usha JD; Vijayamma Anilkumar T; Srinivas P
Carcinogenesis; 2020 Jul; 41(5):611-624. PubMed ID: 31219560
[TBL] [Abstract] [Full Text] [Related]
5. β-hCG-induced mutant BRCA1 ignites drug resistance in susceptible breast tissue.
Sengodan SK; Hemalatha SK; Nadhan R; Somanathan T; Mathew AP; Chil A; Kopczynski J; Nair RS; Kumar JM; Srinivas P
Carcinogenesis; 2019 Nov; 40(11):1415-1426. PubMed ID: 30963174
[TBL] [Abstract] [Full Text] [Related]
6. Management of placental site trophoblastic tumor: Two case reports.
De Nola R; Schönauer LM; Fiore MG; Loverro M; Carriero C; Di Naro E
Medicine (Baltimore); 2018 Nov; 97(48):e13439. PubMed ID: 30508960
[TBL] [Abstract] [Full Text] [Related]
7. Human Chorionic Gonadotropin and breast cancer.
Schüler-Toprak S; Treeck O; Ortmann O
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28754015
[TBL] [Abstract] [Full Text] [Related]
8. Recognition based hormonal 95kDa monoclonal antibody on three human cancer cell lines for developing targeted radio-immuno-imaging and therapy.
Bandopadhyaya GP; Arora G; Shukla J; Ghosh S
Hell J Nucl Med; 2012; 15(2):108-13. PubMed ID: 22833856
[TBL] [Abstract] [Full Text] [Related]
9. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
10. Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines.
Francia G; Emmenegger U; Lee CR; Shaked Y; Folkins C; Mossoba M; Medin JA; Man S; Zhu Z; Witte L; Kerbel RS
Mol Cancer Ther; 2008 Oct; 7(10):3452-9. PubMed ID: 18852148
[TBL] [Abstract] [Full Text] [Related]
11. Human chorionic gonadotropin (hCG) and prevention of breast cancer.
Janssens JP; Russo J; Russo I; Michiels L; Donders G; Verjans M; Riphagen I; Van den Bossche T; Deleu M; Sieprath P
Mol Cell Endocrinol; 2007 Apr; 269(1-2):93-8. PubMed ID: 17386970
[TBL] [Abstract] [Full Text] [Related]
12. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hcg C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
Yi H; Rong Y; Yankai Z; Wentao L; Hongxia Z; Jie W; Rongyue C; Taiming L; Jingjing L
Vaccine; 2006 Mar; 24(14):2575-84. PubMed ID: 16420967
[TBL] [Abstract] [Full Text] [Related]
13. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract] [Full Text] [Related]
14. [Diagnostic management of inaugurable metastases].
Penel N
Presse Med; 2003 Jun; 32(21):990-6, 1004. PubMed ID: 12876530
[TBL] [Abstract] [Full Text] [Related]
15. Serum levels of tumor markers and presence of human antimouse antibodies: implications for diagnosis and treatment with radiolabeled monoclonal antibodies.
Bouvier JF; Pernod J; Rivoire M; Maiassi N
Cancer Detect Prev; 1988; 13(3-4):251-62. PubMed ID: 2468412
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
[TBL] [Abstract] [Full Text] [Related]
17. Serum tumor markers in metastatic breast cancer and course of disease.
Caffier H; Brandau H
Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
[TBL] [Abstract] [Full Text] [Related]
